BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33328727)

  • 1. Intracellular Quantification and Localization of Label-Free Iron Oxide Nanoparticles by Holotomographic Microscopy.
    Friedrich RP; Schreiber E; Tietze R; Yang H; Pilarsky C; Alexiou C
    Nanotechnol Sci Appl; 2020; 13():119-130. PubMed ID: 33328727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometry for intracellular SPION quantification: specificity and sensitivity in comparison with spectroscopic methods.
    Friedrich RP; Janko C; Poettler M; Tripal P; Zaloga J; Cicha I; Dürr S; Nowak J; Odenbach S; Slabu I; Liebl M; Trahms L; Stapf M; Hilger I; Lyer S; Alexiou C
    Int J Nanomedicine; 2015; 10():4185-201. PubMed ID: 26170658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular SPION Uptake and Toxicity in Various Head and Neck Cancer Cell Lines.
    Balk M; Haus T; Band J; Unterweger H; Schreiber E; Friedrich RP; Alexiou C; Gostian AO
    Nanomaterials (Basel); 2021 Mar; 11(3):. PubMed ID: 33805818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of potential iron oxide nanoparticles for breast cancer treatment based on in vitro cytotoxicity and cellular uptake.
    Poller JM; Zaloga J; Schreiber E; Unterweger H; Janko C; Radon P; Eberbeck D; Trahms L; Alexiou C; Friedrich RP
    Int J Nanomedicine; 2017; 12():3207-3220. PubMed ID: 28458541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitoxantrone and Mitoxantrone-Loaded Iron Oxide Nanoparticles Induce Cell Death in Human Pancreatic Ductal Adenocarcinoma Cell Spheroids.
    Dinter J; Friedrich RP; Yang H; Pilarsky C; Mangge H; Pöttler M; Janko C; Alexiou C; Lyer S
    Materials (Basel); 2023 Apr; 16(7):. PubMed ID: 37049199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A reliable protocol for colorimetric determination of iron oxide nanoparticle uptake by cells.
    Deda DK; Cardoso RM; Uchiyama MK; Pavani C; Toma SH; Baptista MS; Araki K
    Anal Bioanal Chem; 2017 Nov; 409(28):6663-6675. PubMed ID: 28918472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological impact of superparamagnetic iron oxide nanoparticles for magnetic particle imaging of head and neck cancer cells.
    Lindemann A; Lüdtke-Buzug K; Fräderich BM; Gräfe K; Pries R; Wollenberg B
    Int J Nanomedicine; 2014; 9():5025-40. PubMed ID: 25378928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superparamagnetic iron-oxide nanoparticles mPEG350- and mPEG2000-coated: cell uptake and biocompatibility evaluation.
    Silva AH; Lima E; Mansilla MV; Zysler RD; Troiani H; Pisciotti MLM; Locatelli C; Benech JC; Oddone N; Zoldan VC; Winter E; Pasa AA; Creczynski-Pasa TB
    Nanomedicine; 2016 May; 12(4):909-919. PubMed ID: 26767515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Iron-Oxide Nanoparticle Surface Chemistry on Uptake Kinetics and Cytotoxicity in CHO-K1 Cells.
    Hanot CC; Choi YS; Anani TB; Soundarrajan D; David AE
    Int J Mol Sci; 2015 Dec; 17(1):. PubMed ID: 26729108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Superparamagnetic Iron Oxide Nanoparticles on Vocal Fold Fibroblasts: Cell Behavior and Cellular Iron Kinetics.
    Pöttler M; Fliedner A; Schreiber E; Janko C; Friedrich RP; Bohr C; Döllinger M; Alexiou C; Dürr S
    Nanoscale Res Lett; 2017 Dec; 12(1):284. PubMed ID: 28431461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Superparamagnetic Iron Oxide Nanoparticles on THP-1 Monocytes and Monocyte-Derived Macrophages.
    Polasky C; Studt T; Steuer AK; Loyal K; Lüdtke-Buzug K; Bruchhage KL; Pries R
    Front Mol Biosci; 2022; 9():811116. PubMed ID: 35211509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxyapatite as a Vehicle for the Selective Effect of Superparamagnetic Iron Oxide Nanoparticles against Human Glioblastoma Cells.
    Pernal S; Wu VM; Uskoković V
    ACS Appl Mater Interfaces; 2017 Nov; 9(45):39283-39302. PubMed ID: 29058880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitoxantrone-loaded superparamagnetic iron oxide nanoparticles as drug carriers for cancer therapy: Uptake and toxicity in primary human tubular epithelial cells.
    Cicha I; Scheffler L; Ebenau A; Lyer S; Alexiou C; Goppelt-Struebe M
    Nanotoxicology; 2016; 10(5):557-66. PubMed ID: 26468004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic pathway and distribution of superparamagnetic iron oxide nanoparticles: in vivo study.
    Schlachter EK; Widmer HR; Bregy A; Lönnfors-Weitzel T; Vajtai I; Corazza N; Bernau VJ; Weitzel T; Mordasini P; Slotboom J; Herrmann G; Bogni S; Hofmann H; Frenz M; Reinert M
    Int J Nanomedicine; 2011; 6():1793-800. PubMed ID: 21980242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accumulation and Toxicity of Superparamagnetic Iron Oxide Nanoparticles in Cells and Experimental Animals.
    Jarockyte G; Daugelaite E; Stasys M; Statkute U; Poderys V; Tseng TC; Hsu SH; Karabanovas V; Rotomskis R
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27548152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantifying intra- and extracellular aggregation of iron oxide nanoparticles and its influence on specific absorption rate.
    Jeon S; Hurley KR; Bischof JC; Haynes CL; Hogan CJ
    Nanoscale; 2016 Sep; 8(35):16053-64. PubMed ID: 27548050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shell matters: Magnetic targeting of SPIONs and in vitro effects on endothelial and monocytic cell function.
    Matuszak J; Dörfler P; Zaloga J; Unterweger H; Lyer S; Dietel B; Alexiou C; Cicha I
    Clin Hemorheol Microcirc; 2015; 61(2):259-77. PubMed ID: 26410877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular interaction of folic acid conjugated superparamagnetic iron oxide nanoparticles and its use as contrast agent for targeted magnetic imaging of tumor cells.
    Kumar M; Singh G; Arora V; Mewar S; Sharma U; Jagannathan NR; Sapra S; Dinda AK; Kharbanda S; Singh H
    Int J Nanomedicine; 2012; 7():3503-16. PubMed ID: 22848174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superparamagnetic Iron Oxide Nanoparticles Modified with Silica Layers as Potential Agents for Lung Cancer Treatment.
    Reczyńska K; Marszałek M; Zarzycki A; Reczyński W; Kornaus K; Pamuła E; Chrzanowski W
    Nanomaterials (Basel); 2020 May; 10(6):. PubMed ID: 32486431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface engineering of iron oxide nanoparticles for targeted cancer therapy.
    Kievit FM; Zhang M
    Acc Chem Res; 2011 Oct; 44(10):853-62. PubMed ID: 21528865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.